C. Schmidt, “The utility of procalcitonin as a biomarker of hospital-acquired infection in severe COVID-19”, Afr J Thoracic Crit Care Med, vol. 30, no. 4, p. e1617, Dec. 2024, doi: 10.7196/AJTCCM.2024.v30i4.1617.